Oncotarget

Research Papers:

The Nterminal tail coordinates with carbohydrate recognition domain to mediate galectin3 induced apoptosis in T cells

PDF  |  Full Text  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:49824-49838. https://doi.org/10.18632/oncotarget.17760

Metrics: PDF 1918 views  |  Full Text 3945 views

Huiting Xue1, Lu Liu1, Zihan Zhao1, Zhongyu Zhang1, Yuan Guan1, Hairong Cheng1, Yifa Zhou1 and Guihua Tai1

1School of Life Sciences, Northeast Normal University, Changchun, China

Correspondence to:

Guihua Tai, email: [email protected]

Keywords: galectin-3, apoptosis, ERK, ROS, truncated protein

Received: September 12, 2016    Accepted: April 24, 2017    Published: May 10, 2017

ABSTRACT

Galectin-3 is a galectin with a unique flexible N-terminal tail (NT) connected to the conserved carbohydrate recognition domain (CRD). Galectin-3 is associated with tumor immune tolerance and exhibits an ability to induce T cell apoptosis. We used Jurkat, Jurkat E6-1 and CEM T-cell lines and human peripheral blood mononuclear cells (PBMCs) to investigate the specific roles of the CRD and NT in inducing T cell apoptosis. Galectin-3 triggered sustained extracellular signal-regulated kinase (ERK) phosphorylation that induced apoptosis. ERK was situated upstream of caspase-9 and was independently activated by reactive oxygen species (ROS) and protein kinase C (PKC). The first twelve NT residues had no role in the apoptosis. Residues 13-68 were essential for activating ROS, but did not activate PKC. However, residues 69-110 were required for activation of PKC. An NT fragment and a NT-specific antibody antagonized the apoptosis triggered by full-length galectin-3 further supporting our findings. These findings indicate the CRD and NT play important roles during induction of T cell apoptosis, which suggests their potential as therapeutic targets for reversing cancer immune tolerance.